Sa1522 EFFICACY AND SAFETY OF SWITCHING TO TENOFOVIR ALAFENAMIDE IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B PATIENTS WITH RENAL IMPAIRMENT: WEEK 24 RESULTS FROM A PHASE 2 OPEN-LABEL STUDY

Autor:	Susanna K. Tan, Shuyuan Mo, John F. Flaherty, Chi-Yi Chen, Pietro Lampertico, Wan-Long Chuang, Sarjita Naik, Anuj Gaggar, Ho Bae, Leland J. Yee, Syed-Mohammed Jafri, Carla S. Coffin, Harry L.A. Janssen, Young-Suk Lim, Claire Fournier, Jeong Heo, Huy N. Trinh
Rok vydání:	2020
Předmět:	medicine.medical_specialty Hepatology Chronic hepatitis Open label study business.industry Internal medicine Gastroenterology Medicine business Tenofovir alafenamide
Zdroj:	Gastroenterology. 158:S-1319
ISSN:	0016-5085
DOI:	10.1016/s0016-5085(20)33967-6
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::247046e7a73a5b03b187484ec55987e0 https://doi.org/10.1016/s0016-5085(20)33967-6 Zobrazit plný text záznamu